Scientists use vectors to carry a DNA segment, and thus are a necessary component in genetic engineering and some animal vaccine development. We can create vaccines for well-known illnesses in animals like influenza, West Nile virus, and rabies. #ABCsofClimateTech
Biotechnology Innovation Organization
Biotechnology Research
Washington, DC 92,138 followers
BIO, Where breakthroughs begin
About us
BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.
- Website
-
http://www.bio.org
External link for Biotechnology Innovation Organization
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Washington, DC
- Type
- Nonprofit
- Founded
- 1993
- Specialties
- biotech, association, life sciences, biofuels, gmo, cures, energy, agriculture, and pharmaceuticals
Locations
-
Primary
1201 New York Ave N.W.
Suite 1300
Washington, DC 20005, US
Employees at Biotechnology Innovation Organization
Updates
-
🎉Congratulations to BIO member Servier Pharmaceuticals on their recent FDA approval for Voranigo!
#BreakingNews We are thrilled to announce that today, the U.S. FDA has approved the first targeted therapy for Grade 2 IDH-mutant glioma. This is the first significant treatment breakthrough for this relentless condition in nearly 25 years. Thank you to the dedicated study participants, researchers, and clinical investigators who made this achievement possible. Learn more about this approval and Servier’s mission to bring transformative new therapies to patients: https://ow.ly/k68U50SRETr
servier.us
-
Biotechnology Innovation Organization reposted this
Honored to be in Atlanta this week leading an educational session with the ever-inspiring Katy Grainger about antimicrobial resistance (#AMR) and, specifically, the impact of AMR on the limb loss and limb difference community. This is my third year joining the Amputee Coalition for their National Conference on behalf of Biotechnology Innovation Organization and words truly cannot capture how moving this event is. Thank you to Ashlie White and Shree Thaker for the invitation to speak and raise awareness about this global public health threat, and the urgent need for policy action to bring new antimicrobial innovations to patients. #ACNC24 #AntimicrobialResistance Sepsis Alliance
-
Maximize growth and minimize costs with BIO Business Solutions®. BIO Members enjoy deep discounts on products tailored for the life sciences industry. https://lnkd.in/gnspKMth
-
Check out the latest episode of the Second Opinion podcast to hear from Daphne Zohar about the complexities of drug development and the opportunities and challenges facing small biotech companies today. Listen now: https://lnkd.in/ekfm2qf8
I answer Christina Farr's question: "Are all these tech VC investing in biotech just dumb money?" and we chat about a range of topics including the Valley of Death, #drugpricing, #Biosecure act, etc. on the very cool new "Second Opinion" podcast w/Ash Zenooz, MD, & Luba Greenwood, J.D. https://lnkd.in/eTkPvVDU
-
Biotechnology Innovation Organization reposted this
HOW DO WE NOT SCREW THIS UP…? This being the Golden Age of Biology and Medicine that we are just entering- the ability to advance treatments, vaccines and cures that we could only dream of until recently? And how do we do this with the greatest sense of urgency. And in a way that ensures universal access to the best medicines for all persons so that no one ever has to go a day without the medicines they need? Listen to this podcast that I did recently with my friend Jorge Conde to hear more of my thoughts on how we don’t screw this up….
Misguided policies can slow innovation and restrict patient access to treatments. John F. Crowley, President & CEO of the Biotechnology Innovation Organization, noted that regulations failing to consider the entire biotech ecosystem can lead to unintended consequences. In conversation with Jorge Conde, Crowley advocates for policies that support innovation and ensure access, always with a patient-centered approach. Listen on Raising Health: https://lnkd.in/g26nuCYX
-
#AMR presents a clear threat to human health and healthcare systems. And in the post-COVID era, the threat and calls to address the issue have increased. Read more on Bio.News: https://lnkd.in/eMuM584p
-
🎉 Congratulations to BIO's John Torres, CAE on being named a USDA-USTR agricultural trade advisor! https://lnkd.in/eBsW47_c
Honored to have been appointed by Secretary Vilsack and Ambassador Tai to serve on USDA's and USTR's Agricultural Trade Advisory Committee for Grains, Feed, Oilseeds, and Planting Seeds on behalf of the Biotechnology Innovation Organization. https://lnkd.in/ept93Rmd
USDA, USTR Name New Agricultural Trade Advisors
usda.gov
-
During an FTC open meeting, members of the public shared emotional stories about how PBM practices increase the cost of drugs, reduce patient access and force independent pharmacies to close. Read more: https://lnkd.in/ewaNeYD8
Emotional testimonies expose harmful impact of PBMs at FTC hearing
https://bio.news
-
Biotechnology Innovation Organization reposted this
PATIENT PERSPECTIVES....this week at BIO we hosted an amazing Dad, my friend and NYC Firefighter, Luke Rosen, to talk about his family's journey into the world of rare diseases. In 2016, Luke and his wife Sally faced the diagnosis of their daughter Susannah ("Suzy") with a rare and fatal neurological disease, KIF1A. Back then, she was only the 7th child in the world known to have this devastating disease. There was no hope. Luke, Sally, family and friends were determined to find more children with KIF1A, and to advance science to a treatment- and ultimately a cure. Through their amazing efforts and their not-for-profit KIF1A.ORG, there are now more than 650 kids with a KIF1A diagnosis. Suzy has now received an experimental small molecule therapy that is bringing hope to her and others. This picture of Suzy (in the red shirt) was taken yesterday at Columbia Children's Hospital in NYC. She is greeting a new friend, little Sloane, who also lives with KIF1A. Sloane is there to receive the same experimental treatment for the first time. Amazing man and family who have brought hope to a small but incredibly important part of the world of genetic medicine. A story of love, hope, persistence, science, medicine, faith and biotechnology. New York City Fire Department Global Genes EveryLife Foundation for Rare Diseases Biotechnology Innovation Organization Columbia Children's Health #biotechnology. #science #medicine #faith #hope